Sponsor content
70 result(s) found, displaying 51 to 60
-
Prescription medicine registrationActive ingredients: Hydrocortisone sodium succinate.
-
Australian public assessment report (AusPar)Bevacip/Bevaciptin (bevacizumab) for the treatment of types of cancer.
-
Cancellation by sponsorRequested by Cipla Australia Pty Ltd
-
Cancellation by sponsorRequested by Cipla Australia Pty Ltd
-
Cancellation by sponsorRequested by Cipla Australia Pty Ltd
-
Cancellation by sponsorRequested by Cipla Australia Pty Ltd
-
Cancellation by sponsorRequested by Cipla Australia Pty Ltd
-
Prescription medicine registrationActive ingredients: isoprenaline hydrochloride.
-
Prescription medicine registrationActive ingredients: dapagliflozin (as propanediol monohydrate).
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2022